|
WO2021053493A1
|
|
Compositions for use in inhibiting src kinase and treating and preventing associated disorders
|
|
WO2020208541A1
|
|
Composition comprising glp-1 analogue
|
|
WO2020188510A2
|
|
Process of preparation of glucagon-like peptide-1 (glp-1) receptor agonists and their analogs
|
|
WO2020161664A2
|
|
Glucagon-like peptide-1 (glp-1) agonist analog, process of preparation and uses thereof
|
|
WO2020012446A1
|
|
Double knock-out cho cell line method of its generation and producing therapeutic proteins therefrom
|
|
AU2019291662A1
|
|
Succinic acid and derivatives for the treatment of haemotological disorders
|
|
WO2020115566A1
|
|
An improved process for the preparation of plecanatide
|
|
WO2020152509A1
|
|
Automated integrated continuous system and bioprocess for producing therapeutic protein
|
|
KR20190064591A
|
|
Continuous process to reduce non-uniformity of therapeutic protein
|
|
WO2014097323A1
|
|
Novel fusion tags and expression vector system for the expression of human parathyroid hormone (rhpth)
|
